Trial Profile
An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Dutasteride/testosterone (Primary) ; Dutasteride; Testosterone
- Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Pharmacokinetics
- 24 Mar 2009 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 04 Sep 2007 Status changed from recruiting to completed.
- 07 Dec 2006 New trial record.